SRHE:XETRA:XETRA-Amundi Index Solutions - Amundi Index MSCI EMU SRI PAB Ucits ETF DR Cap (EUR)

ETF | Others |

Last Closing

USD 93.93

Change

+0.27 (+0.29)%

Market Cap

USD 0.19B

Volume

2.79K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.48%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.02 (+1.04%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.07 (+0.30%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.05 (+0.39%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.05 (+0.97%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.10 (+0.43%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.15 (+1.18%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.30 (+0.55%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.06 (+0.55%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.17 (+0.14%)

USD 12.26B

ETFs Containing SRHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.86% 80% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.86% 81% B- 74% C
Trailing 12 Months  
Capital Gain 13.18% 81% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.18% 81% B- 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.56% 57% F 57% F
Dividend Return 8.56% 56% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.36% 75% C 81% B-
Risk Adjusted Return 116.28% 95% A 95% A
Market Capitalization 0.19B 52% F 39% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike